Congenital factor VII deficiency
MONDO:0009211Factor VII (FVII) deficiency is a rare hereditary hemorrhagic disease caused by the diminution or absence of this coagulation factor.
Also known as: congenital factor VII deficiency, congenital proconvertin deficiency, hypoproconvertinemia, F7 deficiency, factor 7 deficiency, factor VII deficiency
15 clinical trials for this condition and its sub-types, 3 tagged with Congenital factor VII deficiency itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New shot could tame rare bleeding disorder
Disease control Recruiting nowThis study tests a new drug called sutacimig in 18 adults with a rare inherited bleeding disorder (factor VII deficiency). The drug is given as a single shot under the skin to see if it is safe and can help prevent bleeding. The goal is to find a more convenient treatment option …
Phase 2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New shot aims to cut bleeding in hemophilia patients
Disease control Recruiting nowThis study tests an experimental injection called SR604 in 76 adults with hemophilia A, B, or congenital factor VII deficiency. The goal is to see if it is safe and can reduce bleeding episodes. Participants will receive either a single dose or multiple doses, and researchers wil…
Phase 1/2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC